Loading...

Loading...

Chiesi: Writing a Better Future for Patients With Rare Diseases
By Miriam Bello - Mon, 02/08/2021 - 12:48
Driven by the belief that no patient should be left behind, one of the key projects for Chiesi’s Rare Disease division is alpha-mannosidosis.
https://mexicobusiness.news/tag/mhr-2020
More Health
Dialogue is Essential to Ensure Quality Treatments: Chiesi
By Jan Hogewoning - Wed, 01/27/2021 - 21:07
Director General of Chiesi Mexico, Marco Ruggiero explains how medicine purchasing schemes have impacted the industry and Chiesi's place as a provider
Undisrupted Operation Through Effective Planning, Safety Measures
By Miriam Bello - Wed, 01/20/2021 - 19:06
Early planning allowed CHRISTUS MUGUERZA to prepare for the pandemic and ensure ongoing care for non-COVID-19 patients.
USMCA, Other Advantages Propel Medical Devices Sector: AMID
By Miriam Bello - Wed, 01/20/2021 - 17:50
With its significant economic impact, the medical devices sector seeks to strengthen its capabilities and improve care
Connected Health Ecosystem A Lesson and A Challenge From COVID-19
By Miriam Bello - Wed, 01/20/2021 - 17:25
COVID-19 highlighted the flaws and precariousness of the health system in Mexico. Public-private collaboration is the first step toward improvement.
Innovation, Social Responsibility in Mexico’s Southeast
By Miriam Bello - Fri, 01/15/2021 - 18:00
Infrastructure, equipment and medical professionalism enable Faro del Mayab to offer specialized attention in the southeast of the country.
Investment Responds to Patient, Market and Industry Needs
By Miriam Bello - Fri, 11/20/2020 - 09:30
Strategic investment has made Grupo Neolpharma an important partner for both the public and private sectors. Learn why.
Facing the Revolution in Aesthetics
By Miriam Bello - Fri, 11/06/2020 - 17:48
To take advantage of a blooming market, Dr. Frank Rosengaus clinic uses an aesthetics method developed by his founder. Read more about it ihere.
Saving Lives with Faster, Better Diagnostics
By Miriam Bello - Fri, 11/06/2020 - 14:11
bioMérieux is a leader of diagnosis test development, they have used this expertise to develop state-of-the-art COVID-19 with quick, certain results
Alliances Key For Quick, Efficient COVID-19 Vaccine Development
By Miriam Bello - Thu, 11/05/2020 - 15:09
GSK is a global leader in vaccine development. These are the company’s current developments on COVID-19.